Document Detail


Primary angioplasty reduces risk of myocardial rupture compared to thrombolysis for acute myocardial infarction.
MedLine Citation:
PMID:  9328698     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
Although the mechanical complications of acute ventricular septal defect and acute mitral regurgitation are uncommon after acute myocardial infarction, these complications are associated with an extremely high morbidity and mortality. We hypothesized that the administration of thrombolytic drugs may result in hemorrhagic infarction as well as the potential for incomplete revascularization and thus may lead to an increased incidence of mechanical complications compared to primary angioplasty. Accordingly, we reviewed the data of the most contemporary thrombolytic and primary angioplasty trials and compared the incidence of mechanical complications among 36,303 patients treated with thrombolytics reported in the GUSTO trial to the incidence of mechanical complications among 1,295 patients treated with primary angioplasty obtained from the PAMI-1 and PAMI-2 trials. We found that angioplasty resulted in an overall 86% relative risk reduction in mechanical complications (2.20% vs. 0.31%, P < 0.001). In comparison to thrombolytic therapy, angioplasty resulted in an 82% decrease in acute mitral regurgitation (1.73% vs. 0.31%, P < 0.001) and a 100% decrease in acute ventricular septal defect (0.47% vs. 0.00%, P < 0.03). In conclusion, in patients with acute myocardial infarction, reperfusion with primary angioplasty is associated with less myocardial rupture and mechanical complications than thrombolytics. This finding may, in part, explain the improved prognosis observed in myocardial infarction patients treated with primary angioplasty.
Authors:
J W Kinn; W W O'Neill; K H Benzuly; D E Jones; C L Grines
Related Documents :
7798498 - Clinical outcome of deferring angioplasty in patients with normal translesional pressur...
18762688 - Dissection of the right coronary ostium and sinus of valsalva during right coronary art...
2945518 - Catheter reperfusion to allow optimal coronary bypass grafting following failed translu...
8894258 - Plaque removal and thrombus dissolution with the photoacoustic energy of pulsed-wave la...
21762938 - Myocardial remodeling with aortic stenosis and after aortic valve replacement: mechanis...
3376878 - Influence on prognosis and morbidity of left ventricular ejection fraction with and wit...
Publication Detail:
Type:  Clinical Trial; Comparative Study; Journal Article; Meta-Analysis; Randomized Controlled Trial    
Journal Detail:
Title:  Catheterization and cardiovascular diagnosis     Volume:  42     ISSN:  0098-6569     ISO Abbreviation:  Cathet Cardiovasc Diagn     Publication Date:  1997 Oct 
Date Detail:
Created Date:  1997-11-25     Completed Date:  1997-11-25     Revised Date:  2006-11-15    
Medline Journal Info:
Nlm Unique ID:  7508512     Medline TA:  Cathet Cardiovasc Diagn     Country:  UNITED STATES    
Other Details:
Languages:  eng     Pagination:  151-7     Citation Subset:  IM    
Affiliation:
Department of Internal Medicine, William Beaumont Hospital, Royal Oak, Michigan 48073, USA.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Adult
Aged
Angioplasty, Transluminal, Percutaneous Coronary*
Female
Heart Rupture, Post-Infarction / etiology,  prevention & control*
Heart Septal Defects, Ventricular / etiology,  prevention & control
Humans
Male
Middle Aged
Mitral Valve Insufficiency / etiology,  prevention & control
Myocardial Infarction / therapy*
Prognosis
Risk Assessment
Thrombolytic Therapy*
Comments/Corrections
Comment In:
Cathet Cardiovasc Diagn. 1997 Oct;42(2):157   [PMID:  9328699 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Mechanisms of cardiac perforation leading to tamponade in balloon mitral valvuloplasty.
Next Document:  Multiple stent implantation in single coronary arteries: acute results and six-month angiographic fo...